Skip to main content
    I

    Immunic Inc (IMUX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.23
    -0.29 (-3.86%)

    Market Cap: $102.61M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Immunic Inc (IMUX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Immunic (IMUX) to earn -$3.56 per share in the fiscal year ending Dec 31, 2026. Of 13 analysts, 13 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 6 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy13100.0%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    13

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$3.56
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$2.37
    EPS consensus
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$3.56-$5.72 to -$3.0912
    Dec 31, 2027-$2.37-$4.77 to -$0.7011

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.82-$1.23 to -$0.6013

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 12 upward and 5 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202663
    Fiscal year ending Dec 31, 202762

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$4.40.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$3.56-$3.56-$3.57-$3.57-$4.40N/A
    Fiscal year ending Dec 31, 2027-$2.37-$2.36-$2.43-$2.43-$3.63N/A

    Frequently Asked Questions About IMUX

    What is the IMUX stock forecast?

    Consensus analyst estimates put Immunic's EPS at -$3.56 for the fiscal year ending Dec 31, 2026. The consensus rating from 13 analysts is Buy.

    How do analysts rate IMUX stock?

    Of 13 analysts covering Immunic, 0 rate it Strong Buy, 13 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from IMUX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.56, with estimates from -$5.72 to -$3.09 from 12 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.37, with estimates from -$4.77 to -$0.70 from 11 analysts.

    How many analysts cover IMUX?

    13 analysts rate Immunic stock, and 12 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.